Wearable Devices (WLDS) receives $750,000 neurorehab pilot budget deal

Rhea-AI Filing Summary

Wearable Devices Ltd. reports that it received approval for a $750,000 budget to conduct a neurorehabilitation pilot with Soroka Medical Center. This reflects a funded pilot project focused on neurorehabilitation applications.

The report mainly furnishes a press release about this approval as an exhibit and makes the first two paragraphs and the forward-looking statements section part of several existing Form S-8 and Form F-3 registration statements, so that these disclosures are now formally included in those previously filed share registration documents.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

Under the Securities Exchange Act of 1934

For the Month of December 2025 (Report No. 2)

001-41502 (Commission File Number)

WEARABLE DEVICES LTD.

(Exact name of Registrant as specified in its charter)

5 Ha-Tnufa Street

Yokne-am Illit, Israel 2066736

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒       Form 40-F ☐

CONTENTS

Attached hereto and incorporated herein is Wearable Devices Ltd.’s (the “Company”) press release issued on December 11, 2025, titled “Wearable Devices Receives Approval for $750,000 Budget for Neurorehabilitation Pilot with Soroka Medical Center.” 

The first two paragraphs and the section titled “Forward-Looking Statements Disclaimer” in the press release attached hereto as Exhibit 99.1 are incorporated by reference into the registration statements on Form S-8 (File Nos. 333-291857, 333-290148, 333-284010, 333-269869, and 333-274343) and on Form F-3 (File Nos. 333-274841, 333-287247 and 333-291100) of the Company, filed with the SEC, to be a part thereof from the date on which this 6-K is submitted, to the extent not superseded by documents or reports subsequently filed or furnished. 

1

Exhibit Index

Exhibit No.		Description
99.1		Press Release issued by Wearable Devices Ltd. dated December 11, 2025, titled “Wearable Devices Receives Approval for $750,000 Budget for Neurorehabilitation Pilot with Soroka Medical Center.”

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: December 11, 2025	By:	/s/ Asher Dahan
		Asher Dahan
		Chief Executive Officer

3

FAQ

What main development does Wearable Devices Ltd. (WLDS) report in this Form 6-K?

Wearable Devices Ltd. reports that it received approval for a $750,000 budget to run a neurorehabilitation pilot with Soroka Medical Center, and it furnishes a press release on this topic.

How large is the neurorehabilitation pilot budget for Wearable Devices (WLDS)?

The filing highlights approval for a $750,000 budget dedicated to a neurorehabilitation pilot involving Wearable Devices Ltd. and Soroka Medical Center.

Which partner is involved in the neurorehabilitation pilot with Wearable Devices (WLDS)?

The pilot described in the report involves Wearable Devices Ltd. working with Soroka Medical Center on a neurorehabilitation project funded by a $750,000 budget.

How does this Form 6-K affect Wearable Devices Ltd.’s existing registration statements?

The first two paragraphs and the forward-looking statements section of the attached press release are incorporated by reference into Wearable Devices Ltd.’s existing Form S-8 and Form F-3 registration statements, making those disclosures part of those filings.

What document is attached as an exhibit to this Wearable Devices (WLDS) Form 6-K?

The report attaches as Exhibit 99.1 a press release dated December 11, 2025, titled “Wearable Devices Receives Approval for $750,000 Budget for Neurorehabilitation Pilot with Soroka Medical Center.”

Does this Form 6-K include any earnings or financial results for Wearable Devices Ltd.?

The report focuses on approval of a $750,000 budget for a neurorehabilitation pilot and the related press release; it does not present earnings or broader financial results.